Guideline for management of vasculitis syndrome (JCS 2008). Japanese Circulation Society.
| dc.contributor.author | JCS Joint Working Group. | |
| dc.date.accessioned | 2013-04-19T06:58:57Z | |
| dc.date.available | 2013-04-19T06:58:57Z | |
| dc.date.issued | 2011 | |
| dc.description.abstract | Vasculitis syndromes are classified, according to the size of the affected vessels, into large-vessel, medium-vessel, and small-vessel vasculitis (Table 1). Large-sized vessel vasculitis, ie, vasculitis occurring in the aorta and its major branches to the extremities, the head and the neck, includes Takayasu arteritis and temporal arteritis. Medium-sized vessel vasculitis, ie, vasculitis occurring in the major arteries and their branches to the visceral organs, includes polyarteritis nodosa (PAN), Kawasaki disease, and Buerger disease. Small-sized vessel vasculitis occurs in the arterioles, capillaries, and venules. In some cases, small arteries are also affected. Small-sized vessel vasculitis is classified according to the involvement of immune complexes. Vasculitis involving immune complexes include Henoch-Schönlein purpura, essential cryoglobulinemia, and malignant rheumatoid arthritis (MRA) (rheumatoid vasculitis). Small-sized vessel vasculitis not involving immune complexes include microscopic polyangiitis (MPA), Wegener’s granulomatosis, and allergic granulomatous angiitis. Since these three conditions are associated with the presence of marker antibodies, ie | |
| dc.identifier.issn | 1346-9843 | |
| dc.identifier.other | PMID: 21263196 | |
| dc.identifier.uri | http://hdl.handle.net/123456789/881 | |
| dc.language.iso | en | en_GB |
| dc.relation.ispartofseries | Circulation Journal.2011;75(2):474-503. | |
| dc.subject | Vasculitis syndrome | en_GB |
| dc.title | Guideline for management of vasculitis syndrome (JCS 2008). Japanese Circulation Society. | en_GB |
| dc.type | Article | en_GB |
